Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

ANTIBODY TO NATIVE DEOXYRIBONUCLEASE KIT

K-Number: K791928 · 1979-11-13

Decision Date1979-11-13
Product CodeDHN
Advisory CommitteeIM
DecisionSubstantially Equivalent

Device Summary

ANTIBODY TO NATIVE DEOXYRIBONUCLEASE KIT is the device name listed in this FDA 510(k) record. The listed applicant is Keith E. Abbott. It received FDA 510(k) clearance on 1979-11-13 under 510(k) number K791928. The device is classified under product code DHN. It was reviewed by the IM advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the ANTIBODY TO NATIVE DEOXYRIBONUCLEASE KIT?

ANTIBODY TO NATIVE DEOXYRIBONUCLEASE KIT is a medical device that received FDA 510(k) clearance on 1979-11-13. The listed applicant is Keith E. Abbott. The 510(k) number is K791928.

When did ANTIBODY TO NATIVE DEOXYRIBONUCLEASE KIT receive FDA 510(k) clearance?

ANTIBODY TO NATIVE DEOXYRIBONUCLEASE KIT received FDA 510(k) clearance on 1979-11-13, under 510(k) number K791928.

Who is the listed applicant for ANTIBODY TO NATIVE DEOXYRIBONUCLEASE KIT?

The FDA 510(k) record lists Keith E. Abbott as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for ANTIBODY TO NATIVE DEOXYRIBONUCLEASE KIT?

The FDA product code for ANTIBODY TO NATIVE DEOXYRIBONUCLEASE KIT is DHN.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: DHN)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑